OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Systemic and organ-specific anti-inflammatory effects of sodium-glucose cotransporter-2 inhibitors
Mona Mashayekhi, Bilgunay Ilkin Safa, Matthew S.C. Gonzalez, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 5, pp. 425-438
Closed Access | Times Cited: 7
Mona Mashayekhi, Bilgunay Ilkin Safa, Matthew S.C. Gonzalez, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 5, pp. 425-438
Closed Access | Times Cited: 7
Showing 7 citing articles:
Anti-Inflammatory Effects of SGLT2 Inhibitors: Focus on Macrophages
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access | Times Cited: 1
Elena Y. Rykova, Vadim V. Klimontov, Elena Kazakova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1670-1670
Open Access | Times Cited: 1
Inflammatory Trajectory of Type 2 Diabetes: Novel Opportunities for Early and Late Treatment
Valeria Pellegrini, Rosalba La Grotta, Francesca Carreras, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1662-1662
Open Access | Times Cited: 5
Valeria Pellegrini, Rosalba La Grotta, Francesca Carreras, et al.
Cells (2024) Vol. 13, Iss. 19, pp. 1662-1662
Open Access | Times Cited: 5
The Impact of Sodium-Glucose Co-Transporter-2 Inhibition on Insulin Resistance and Inflammation in Patients with Type 2 Diabetes: A Retrospective Study
Liana Iordan, Sandra Lazăr, Romulus Timar, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 209-209
Open Access
Liana Iordan, Sandra Lazăr, Romulus Timar, et al.
Medicina (2025) Vol. 61, Iss. 2, pp. 209-209
Open Access
The inflammation burden index can predict the cardiac injury following antitumour therapy in lung cancer patients with diabetes
Yumin Wang, Chunyan Huan, Guodong Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Yumin Wang, Chunyan Huan, Guodong Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
SGLT2 inhibitor use and renal outcomes in low-risk population with diabetes mellitus and normal or low body mass index
Yun soo Lee, Goeun Park, Kyungho Lee, et al.
BMJ Open Diabetes Research & Care (2025) Vol. 13, Iss. 2, pp. e004876-e004876
Open Access
Yun soo Lee, Goeun Park, Kyungho Lee, et al.
BMJ Open Diabetes Research & Care (2025) Vol. 13, Iss. 2, pp. e004876-e004876
Open Access
SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?
Flavio Tangianu, Eleonora Nicolini, Francesco Dentali, et al.
European Journal of Clinical Investigation (2025)
Open Access
Flavio Tangianu, Eleonora Nicolini, Francesco Dentali, et al.
European Journal of Clinical Investigation (2025)
Open Access
Relative efficacy of five SGLT2 inhibitors: a network meta-analysis of 20 cardiovascular and respiratory outcomes
LiGang Huang, Rong Hu, HaiTao Zou
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
LiGang Huang, Rong Hu, HaiTao Zou
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Intestinal transporters and oral absorption enhancing strategies based on these transporters
Wang Ju, Yongbing Sun, Liangliang Meng, et al.
Chinese Chemical Letters (2024), pp. 110529-110529
Closed Access
Wang Ju, Yongbing Sun, Liangliang Meng, et al.
Chinese Chemical Letters (2024), pp. 110529-110529
Closed Access
